B. Braun Medical Inc. Chosen by Premier for Full-Line Dual-Source Infusion Contract
BETHLEHEM, Pa. -- B. Braun Medical Inc. announced today
that Premier, the nationwide alliance of over 1,500 hospitals and health
systems, selected B. Braun Medical for a full-line, dual-source infusion
contract. The five-year contract valued at $750 million annually is
effective February 1, 2004 and encompasses all major B. Braun Medical
product lines including B. Braun's key safety products.
Through this new contract, Premier members will have access to B. Braun's
award-winning, safety-engineered infusion products including the Outlook(tm)
Safety Infusion System, Introcan Safety* IV Catheter, ULTRASITE* Needle-Free
IV System, Excel* PVC-Free/DEHP-Free IV Containers, and DUPLEX* Drug
Delivery System.
"Through our partnership with Premier, we will have the ability to reach
their more than 1,500 hospitals and healthcare facilities in the United
States," said Caroll H. Neubauer, chairman and CEO of B.
Braun Medical Inc. "We are confident that Premier members will benefit from
access to our infusion products, which are designed to enhance both
clinician and patient safety."
"In addition to B. Braun gaining access to 1,500 of the nation's leading
health institutions and systems, Premier alliance participants will be able
to tap into our global knowledge in drug-administration safety," said Manny
Losada, senior vice president of sales for B. Braun Medical Inc. "By
evaluating our full-line of infusion products, hospital staff can learn more
about how technology can help supplement training, address nursing shortages
while providing adherence to best-practice procedures...all with a goal to
reduce medical errors."
Source: B. Braun
Newsletter
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
A Helping Hand: Innovative Approaches to Expanding Hand Hygiene Programs in Acute Care Settings
July 9th 2025Who knew candy, UV lights, and a college kid in scrubs could double hand hygiene adherence? A Pennsylvania hospital’s creative shake-up of its infection prevention program shows that sometimes it takes more than soap to get hands clean—and keep them that way.
